New York: Children from 5 to 11 years old in the United States may soon be able to receive a low-dose Covid-19 vaccine developed by Pfizer-BioNTech, after CDC experts unanimously voted to approve the vaccination doses for this age group, which numbers roughly 28 million. "If CDC Director Rochelle Walensky endorses the suggestions, children might start getting vaccinations within the next few days," according to National Public Radio (NPR).

On Friday, the US Food and Drug Administration (FDA) approved the vaccine for emergency use in children aged 5 to 11. In young children, the FDA approved a 10-microgram dose of Pfizer's vaccine. According to accounts, the first dose given to persons aged 12 and up was 30 mcg. The vaccine dose is one-third that of an adult, and it is administered in two doses three weeks apart. According to Pfizer, the lower dose was chosen to reduce unwanted effects while still producing high immunity.

The government has purchased enough of the low-dose children's vaccine for everyone in this age group, according to White House Covid-19 Response Coordinator Jeffrey Zients. According to the most recent data from the CDC, Covid-19 has killed 172 children aged 5 to 11 in the United States, and more than 8,300 have been hospitalised.

PM Modi to assess COVID vaccination in low-coverage districts on Wednesday

The first shipment of Moderna Covid vaccine arrives in Egypt

'Indian vaccine should be recognised by WHO at the earliest,' PM Modi at G20 conference